文献速递流行病学与生物统计临床试验与 GCP新药、器械与细胞基因治疗研发

胃癌

Gastric cancer.
PubMed 文献 · Lancet · 2025-05-01

发病率在地理上差异显著,亚洲、南美洲和东欧较高,且50岁以下早发性病例快速增加。关键风险因素包括幽门螺杆菌感染、饮食、肥胖、吸烟和遗传易感性;早期发现对优化治疗结果至关重要,局部进展期标准治疗包括手术切除(特别是D2淋巴结清扫)联合化疗和放疗,微创手术及免疫检查点抑制剂和靶向治疗的应用日益增多,新兴疗法在改善生存和生活质量方面显示前景,未来方向聚焦精准医学、免疫治疗进展、新早期检测方法和多学科诊疗。

要点

  • 发病率在亚洲、南美洲和东欧较高,50岁以下早发性病例快速增加。
  • 关键风险因素包括幽门螺杆菌感染、饮食、肥胖、吸烟和遗传易感性。

核心结论

  • 胃癌仍是全球重大健康挑战,未来管理方向包括精准医学、免疫治疗进展、新早期检测方法和多学科诊疗,旨在提高全球治疗有效性和预后。

研究设计与样本

  • 本文为综述,检索范围未在原文中报告。

主要发现

  • 发病率地理差异显著,亚洲、南美洲和东欧较高,50岁以下早发性病例快速增加。
  • 关键风险因素包括幽门螺杆菌感染、饮食、肥胖、吸烟和遗传易感性。
  • 局部进展期标准治疗包括手术切除(特别是D2淋巴结清扫)联合化疗和放疗。
  • 微创手术在可手术疾病中应用增加,免疫检查点抑制剂和靶向治疗在晚期阶段整合应用增多。

关键数值与推荐

  • 早期发现通过全面诊断程序对优化治疗结果至关重要。
  • 局部进展期胃癌标准治疗方法包括手术切除,特别是D2淋巴结清扫,辅以化疗和放疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gastric cancer remains a major health challenge worldwide, with nearly 1 million new cases annually contributing to more than 650 000 deaths. Epidemiologically, gastric cancer shows substantial geographical variation in incidence, with higher rates in Asia, South America, and eastern Europe, and a rapid increase in early-onset cases among people younger than 50 years. Key risk factors for gastric cancer include Helicobacter pylori infection, diet, obesity, smoking, and genetic predisposition. Early detection through comprehensive diagnostic procedures is crucial for optimising treatment outcomes. Standard treatment approaches for locally advanced gastric cancer include surgical resection, particularly D2 lymphadenectomy, complemented by chemotherapy and radiotherapy. There is increasing implementation of minimally invasive surgical techniques for operable disease and integration of immune checkpoint inhibitors and targeted therapies for advanced stages. Emerging therapies, such as novel targeted treatments and next-generation immunotherapies, show promise in improving survival and quality of life. Future directions in the management of gastric cancer focus on precision medicine, continued advancement in immunotherapy, novel early detection methods, and a multidisciplinary approach to care. These strategies aim to enhance the overall effectiveness of treatment and prognosis worldwide.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Sundar R, Nakayama I, Markar SR, et al. Gastric cancer. Lancet. 2025. PMID: 40319897. doi:10.1016/S0140-6736(25)00052-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。